A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.

Antimicrob Agents Chemother

Department of Medical Microbiology, Medical School, University of Birmingham, Edgbaston, United Kingdom.

Published: May 1992

An enoxacin-resistant Pseudomonas aeruginosa mutant (G49) isolated during patient therapy was characterized in detail. The G49 mutant was cross resistant to several classes of antibiotics including quinolones, beta-lactams, chloramphenicol, and tetracycline, but not imipenem or aminoglycosides. Compared with its paired pretherapy isolate G48, this mutant had several alterations in outer membrane proteins including a complete loss of the major porin protein OprF and a substantially altered lipopolysaccharide profile. Revertants were selected at a frequency of approximately 1% after enrichment for OprF+ cells on low-salt proteose peptone no. 2 medium. Ninety-seven of these OprF+ revertants were as susceptible to carbenicillin and norfloxacin as the pretherapy isolate. One of these revertants was characterized in more detail and shown to be indistinguishable in all properties from the pretherapy isolate. It is proposed that the multiple-antibiotic-resistance (Mar) phenotype of this mutant resulted from a single pleiotropic mutation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC188835PMC
http://dx.doi.org/10.1128/AAC.36.5.1057DOI Listing

Publication Analysis

Top Keywords

pretherapy isolate
12
pseudomonas aeruginosa
8
characterized detail
8
mutant
5
pleiotropic posttherapy
4
posttherapy enoxacin-resistant
4
enoxacin-resistant mutant
4
mutant pseudomonas
4
aeruginosa enoxacin-resistant
4
enoxacin-resistant pseudomonas
4

Similar Publications

Ceftazidime-avibactam (CZA) is employed for the treatment of infections caused by carbapenemase-producing (KPC-KP). Resistance to CZA is frequently linked to point mutations in the . We conducted simulations of mutations using CZA.

View Article and Find Full Text PDF

Background: Clinical drawback in checkpoint inhibitors immunotherapy (ICI) of metastatic melanoma (MM) is monitoring clinical benefit. Soluble forms of PD1(sPD1) and PD-L1(sPD-L1) and extracellular vesicles (EVs) expressing PD1 and PD-L1 have recently emerged as predictive biomarkers of response. As factors released in the blood, EVs and soluble forms could be relevant in monitoring treatment efficacy and adaptive resistance to ICI.

View Article and Find Full Text PDF

Introduction: Increasingly, early-stage non-small cell lung cancer (NSCLC) is treated with stereotactic body radiation therapy (SBRT). Although treatment is generally effective, a small subset of tumors will recur because of radioresistance. Preclinical studies suggested PI3K-AKT-mTOR activation mediates radioresistance.

View Article and Find Full Text PDF

Background: Critical coarctation of the aorta (CoA) is a life-threatening condition in newborns that is associated with biventricular dysfunction.

Objectives: The purpose of this study was to examine clinical outcome and echocardiographic changes in isthmus diameter and biventricular function in newborns with critical CoA treated with balloon dilation/stent placement or surgery.

Methods: This is a retrospective single-center cohort study of 26 consecutive neonates with isolated critical CoA, who underwent transcatheter intervention (balloon angioplasty/stent; n = 10) or surgical CoA-repair (n = 16) (2012-2021).

View Article and Find Full Text PDF
Article Synopsis
  • Periodontal inflammation is primarily influenced by macrophage infiltration, with their polarization significantly impacting inflammation and tissue repair.
  • A study evaluated gingival biopsies from individuals with periodontitis before and after non-surgical therapy, finding a shift in macrophage polarization from pro-inflammatory (M1) to anti-inflammatory (M2) markers post-treatment.
  • These results indicate that successful periodontal therapy may enhance a pro-resolution environment, as evidenced by improved clinical parameters and a decrease in harmful bacterial presence.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!